Clinical trial
Effect of Bosentan in the Course of Scleroderma Renal Crisis
NCT01241383 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Bosentan in the Course of Scleroderma Renal Crisis
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 6, 2010
- Completion date
- June 30, 2016
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
scleroderma renal crisis